Pharmacy and Biomedical Sciences

Stephen Arkle

Dr. Stephen Arkle

Head of School

Pharmacy and Biomedical Sciences

Division of Pharmacology
School of Pharmacy and Biomedical Sciences
University of Portsmouth
St Michael's Building
White Swan Road
Portsmouth
PO1 2DT

stephen.arkle@port.ac.uk

Profile

Qualifications

BSc, PhD

Internal memberships / posts

Associate Dean (Academic)
Associate Head of School
Head of Pharmacology Division
Chair of Unit Exam Board
Chair of Progression Award Exam Board

External memberships / posts

Member of the British Pharmacological Society
LTSN representative
External Examiner for:
Health & Biosciences at Leeds Metropolitan University;
Applied Science at University of the West of England;
Adult & Continuing Care Nursing at University of the West of England.

Key teaching responsibilities

Level 1:  Pharmacodynamics; electrophysiology; communication skills.

Level 2:  Pharmacologic analyses; drug development.

Level 3: Recombinant DNA technology; electrophysiology; signal transduction; pharmacology projects

Key research interests

Purinoceptor pharmacology, ion transport processes.

Recent Publications

 

More recent publications

 

Publications before 2008

Yeung D, Zablocki K, Jiang T, Arkle S, Brown J, Lochmüller H, Simon J, Barnard E & Górecki D, Abnormality of P2X receptor function and increased ATP-evoked muscle cell death in mdx dystrophic myoblasts, FASEB J., in press 2005.

Arkle S, Arkle M & Ebenezer I, A comparison of the effects of the 5HT1A antagonists MM-77 and WAY-100635 on the mouse isolated vasa deferentia, Auton Autacoid Pharmacol., 25, 121-128, 2005.

Arkle S, Górecki D, Idris M, Lodmüller H & Yeung D, Purinergic responses in SC5 and IMO skeletal muscle cell lines and phrenic nerve-diaphragm preparations from C57BL and MDX mice. Proc. Br. Pharmacol. Soc., Available at http://www.pa2online.org/Vol2Issue4abst108P.html, 2005.

Arkle MJ, Arkle S & Ebenezer IS, A comparison of the effects of the putative 5HT1A antagonist MM-77 with WAY-100635 on the mouse isolated vasa deferentia, Proc. Br. Pharmacol. Soc, 2004.